MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Utility of Eye Movement Abnormalities in Differentiating Neurodegenerative versus non-Neurodegenerative Parkinsonism

    A. Margolius, D. Hengartner, O. Hogue, X. Garcia, S. Patel, A. Ahmed, H. Fernandez, XX. Yu (Bogota, Colombia)

    Objective: To evaluate eye movement abnormalities in patients with neurodegenerative versus non-neurodegenerative parkinsonism. Background: Clinical distinction between neurodegenerative and non-neurodegenerative parkinsonism can be difficult[1]. Eye…
  • 2019 International Congress

    Differentiation of Progressive Supranuclear Paralysis from Multisystem Atrophy and Parkinson’s Disease by Cranial MRI

    E. Natera-Villalba, V. Ros-Castelló, A. Sánchez-Sánchez, A. Gómez-López, P. Pérez-Torre, JL. López Sendón, I. Parées-Moreno, JC. Martínez-Castrillo, A. Alonso-Cánovas (Madrid, Spain)

    Objective: To assess differences in cranial MRI between progressive supranuclear palsy (PSP), multisystem atrophy (MSA) and Parkinson's disease (PD) that support the clinical diagnosis. Background:…
  • 2019 International Congress

    Comorbid Parkinson’s disease in a Korean patient with Alexander’s disease

    KY. Kwon, JW. Cho, JK. Park (Seoul, Republic of Korea)

    Objective: We report a unique case of genetically diagnosed Alexander's disease comorbid, with clinically diagnosed Parkinson's disease. Background: Alexander disease is a neurological disease, that causes…
  • 2019 International Congress

    Risk of Parkinson’s in idiopathic anosmia

    R. Rees, S. Gane, C. Philpott, A. Noyce, A. Schrag (Norwich, United Kingdom)

    Objective: To identify markers of increased risk of Parkinson’s in a cohort of individuals with idiopathic anosmia Background: Smell loss (anosmia) is a common finding…
  • 2019 International Congress

    BST1 rs4698412 allelic variant increases the risk of gait or balance deficits in patients with Parkinson’s disease

    Y. Shen, J. Wang, K. Zhang (Nanjing, China)

    Objective: We aimed to explore effects of bone marrow stromal cell antigen‐1 (BST1) rs4698412 allelic variant on brain activation and associative clinical symptoms in Parkinson’s…
  • 2019 International Congress

    Successful treatment of Parkinson’s disease-related impulse control disorder with bilateral STN DBS

    T. Stiep, D. Spengler Shpiner, C. Luca (Miami, FL, USA)

    Objective: To present a case of Parkinson’s disease (PD) complicated by impulse control disorder (ICD) which improved following deep brain stimulation (DBS) targeting the bilateral…
  • 2019 International Congress

    Clinical comparison of right onset PD vs left onset PD

    B. Tserensodnom (Ulaanbaatar, Mongolia)

    Objective: To compare clinical characteristics in right side onset versus left side onset of Parkinson’s disease and evaluate whether side of onset was predictive of…
  • 2019 International Congress

    The role of Dopamine in Preparatory Inhibition: What can we learn from Parkinson’s disease?

    E. Wilhelm, C. Quoilin, G. Derosiere, A. Jeanjean, J. Duqué (Brussels, Belgium)

    Objective: Investigating the influence of dopamine on motor inhibition during action preparation. Background: By measuring the amplitude of motor-evoked potentials (MEPs) elicited by transcranial magnetic…
  • 2019 International Congress

    Factors associated with dyskinesia in Parkinson’s disease in Mainland China

    X. Zhou, LF. Fang, XT. Zhou, XX. Zhou, YW. Zhao, LX. Qin, Y. Tian, ZQ. Wang, QY. Sun, Q. Xu, JC. Li, JF. Guo, XX. Yan, BS. Tang (Changsha, China)

    Objective: To identify the association between dyskinesia and related risk factors, the medication dosage range considered safe and treatment-related variables.To identify the association between dyskinesia…
  • 2019 International Congress

    “Best practice” guidelines for the collection and analysis of speech data in patients with Parkinson’s Disease (PD).

    E. Tripoliti, L. Ramig (Boulder Colorado, CO, USA)

    Objective: To discuss the literature for collection and analysis of speech data for patients with PD in order to create “best practice” guidelines. Background: Speech…
  • « Previous Page
  • 1
  • …
  • 220
  • 221
  • 222
  • 223
  • 224
  • …
  • 425
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley